Found 43 matching trials
Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease PHASE1 A Phase I clinical trial to determine the safety and tolerability of an ant...
Show More Location
University of California, San Diego
Learn More & Join Trial
Interest of Dosage of Anti-PB230, Anti-PB180 and Cytokines for Monitoring of Patients Suffering From Bullous Pemphigoid N/A Bullous pemphigoid is the most common subepidermal autoimmune blistering di...
Show More Learn More & Join Trial
Ibd CAncer and seRious Infections in France (I-CARE 2) N/A This is a French prospective longitudinal observational multicentre cohort ...
Show More Location
CHU Amiens Picardie
Learn More & Join Trial
Ustekinumab for the Treatment of Giant Cell Arteritis PHASE1 The purpose of this study is to determine whether ustekinumab is effective ...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Biomarkers in Participants With Hidradenitis Suppurativa Receiving Guselkumab. EARLY_PHASE1 Hidradenitis Suppurativa (HS) is a severe, chronic debilitating disease wit...
Show More Location
Rockefeller Unviersity
Learn More & Join Trial
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis PHASE2 The main purpose of this study is to determine the safety and efficacy of e...
Show More Location
AZ Gastro Care - Chandler
Learn More & Join Trial
A Safety Study of Mirikizumab (LY3074828) PHASE1 The main purpose of this study is to evaluate the safety of the study drug ...
Show More Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Learn More & Join Trial
Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease PHASE2 A Phase 2b study to evaluate the efficacy and safety of brazikumab (MEDI207...
Show More Location
Arizona Arthritis & Rheumatology Research, PLLC
Learn More & Join Trial
Efficacy, Safety and Pharmacokinetics of BI 655066/ABBV-066 (Risankizumab) in Patients With Active, Moderate-to-severe Crohn's Disease. PHASE2 This study is a proof of concept, multi-center, randomized, double-blind, p...
Show More Location
Multiple Locations
Learn More & Join Trial
Mechanism of Action of Ustekinumab in Psoriatic Arthritis N/A The purpose of this study is to determine the mechanism of action on target...
Show More Location
Academic Medical Center Amsterdam
Learn More & Join Trial